Preclinical Study Shows Targeted Drug Boosts CAR T-Cell Therapy in Pediatric Leukemias
January 3, 2025
A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib (brand name Xospata), a targeted cancer treatment, can